Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

BACKGROUND: Tumours contain hypoxic regions that select for an aggressive cell phenotype; tumour hypoxia induces metastasis-associated genes. Treatment refractory patients with metastatic cancer show increased numbers of circulating tumour cells (CTCs), which are also associated with disease progre...

Full description

Bibliographic Details
Main Authors: Ameri, K, Luong, R, Zhang, H, Powell, A, Montgomery, K, Espinosa, I, Bouley, D, Harris, A, Jeffrey, S
Format: Journal article
Language:English
Published: 2010
_version_ 1797059078794510336
author Ameri, K
Luong, R
Zhang, H
Powell, A
Montgomery, K
Espinosa, I
Bouley, D
Harris, A
Jeffrey, S
author_facet Ameri, K
Luong, R
Zhang, H
Powell, A
Montgomery, K
Espinosa, I
Bouley, D
Harris, A
Jeffrey, S
author_sort Ameri, K
collection OXFORD
description BACKGROUND: Tumours contain hypoxic regions that select for an aggressive cell phenotype; tumour hypoxia induces metastasis-associated genes. Treatment refractory patients with metastatic cancer show increased numbers of circulating tumour cells (CTCs), which are also associated with disease progression. The aim of this study was to examine the as yet unknown relationship between hypoxia and CTCs. METHODS: We generated human MDA-MB-231 orthotopic xenografts and, using a new technology, isolated viable human CTCs from murine blood. The CTCs and parental MDA-MB-231 cells were incubated at 21 and 0.2% (hypoxia) oxygen, respectively. Colony formation was assayed and levels of hypoxia- and anoxia-inducible factors were measured. Xenografts generated from CTCs and parental cells were compared. RESULTS: MDA-MB-231 xenografts used to generate CTCs were hypoxic, expressing hypoxia factors: hypoxia-inducible factor1 alpha (HIF1alpha) and glucose transporter protein type 1 (GLUT1), and anoxia-induced factors: activating transcription factor 3 and 4 (ATF3 and ATF4). Parental MDA-MB-231 cells induced ATF3 in hypoxia, whereas CTCs expressed it constitutively. Asparagine synthetase (ASNS) expression was also higher in CTCs. Hypoxia induced ATF4 and the HIF1alpha target gene apelin in CTCs, but not in parental cells. Hypoxia induced lower levels of carbonic anhydrase IX (CAIX), GLUT1 and BCL2/adenovirus E1B 19-KD protein-interacting protein 3 (BNIP3) proteins in CTCs than in parental cells, supporting an altered hypoxia response. In chronic hypoxia, CTCs demonstrated greater colony formation than parental cells. Xenografts generated from CTCs were larger and heavier, and metastasised faster than MDA-MB-231 xenografts. CONCLUSION: CTCs show an altered hypoxia response and an enhanced aggressive phenotype in vitro and in vivo.
first_indexed 2024-03-06T19:59:11Z
format Journal article
id oxford-uuid:26ae9161-bfd6-465c-b530-87f1fb5015ce
institution University of Oxford
language English
last_indexed 2024-03-06T19:59:11Z
publishDate 2010
record_format dspace
spelling oxford-uuid:26ae9161-bfd6-465c-b530-87f1fb5015ce2022-03-26T12:02:24ZCirculating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:26ae9161-bfd6-465c-b530-87f1fb5015ceEnglishSymplectic Elements at Oxford2010Ameri, KLuong, RZhang, HPowell, AMontgomery, KEspinosa, IBouley, DHarris, AJeffrey, S BACKGROUND: Tumours contain hypoxic regions that select for an aggressive cell phenotype; tumour hypoxia induces metastasis-associated genes. Treatment refractory patients with metastatic cancer show increased numbers of circulating tumour cells (CTCs), which are also associated with disease progression. The aim of this study was to examine the as yet unknown relationship between hypoxia and CTCs. METHODS: We generated human MDA-MB-231 orthotopic xenografts and, using a new technology, isolated viable human CTCs from murine blood. The CTCs and parental MDA-MB-231 cells were incubated at 21 and 0.2% (hypoxia) oxygen, respectively. Colony formation was assayed and levels of hypoxia- and anoxia-inducible factors were measured. Xenografts generated from CTCs and parental cells were compared. RESULTS: MDA-MB-231 xenografts used to generate CTCs were hypoxic, expressing hypoxia factors: hypoxia-inducible factor1 alpha (HIF1alpha) and glucose transporter protein type 1 (GLUT1), and anoxia-induced factors: activating transcription factor 3 and 4 (ATF3 and ATF4). Parental MDA-MB-231 cells induced ATF3 in hypoxia, whereas CTCs expressed it constitutively. Asparagine synthetase (ASNS) expression was also higher in CTCs. Hypoxia induced ATF4 and the HIF1alpha target gene apelin in CTCs, but not in parental cells. Hypoxia induced lower levels of carbonic anhydrase IX (CAIX), GLUT1 and BCL2/adenovirus E1B 19-KD protein-interacting protein 3 (BNIP3) proteins in CTCs than in parental cells, supporting an altered hypoxia response. In chronic hypoxia, CTCs demonstrated greater colony formation than parental cells. Xenografts generated from CTCs were larger and heavier, and metastasised faster than MDA-MB-231 xenografts. CONCLUSION: CTCs show an altered hypoxia response and an enhanced aggressive phenotype in vitro and in vivo.
spellingShingle Ameri, K
Luong, R
Zhang, H
Powell, A
Montgomery, K
Espinosa, I
Bouley, D
Harris, A
Jeffrey, S
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title_full Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title_fullStr Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title_full_unstemmed Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title_short Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
title_sort circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
work_keys_str_mv AT amerik circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT luongr circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT zhangh circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT powella circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT montgomeryk circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT espinosai circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT bouleyd circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT harrisa circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype
AT jeffreys circulatingtumourcellsdemonstrateanalteredresponsetohypoxiaandanaggressivephenotype